IP Library › Granted Patent US 11,104,924
Granted Patent B2
US 11,104,924 · App. 16/473,941 · Granted Aug 31, 2021

Isopropylmalate synthase variant and a method of producing L-leucine using the same

Inventors: Ji Hye Lee (Gyeonggi-do, KR); Byeong Cheol Song (Gyeonggi-do, KR); Ae Ji Jeon (Seoul, KR); Jong Hyun Kim (Gyeonggi-do, KR); Hye Won Kim (Gyeonggi-do, KR)
Assignee: CJ Cheiljedang Corporation
C12P13/06C12N9/1025C12N15/52C12N15/77C12Y203/03013
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,104,924
App. No.
16/473,941
Granted
Aug 31, 2021
Kind
B2
Abstract

A novel modified polypeptide having an isopropylmalate synthase activity, a polynucleotide encoding the same, a microorganism comprising the polypeptide, and a method of producing L-leucine by culturing the microorganism.

Claims (27)

1. A modified polypeptide having an isopropylmalate synthase activity, wherein arginine at position 558 from a N-terminus of a polypeptide consisting of the amino acid sequence of SEQ ID NO: 1 is substituted with histidine, alanine or glutamine; and/or glycine at position 561 from a N-terminus of a polypeptide consisting of the amino acid sequence of SEQ ID NO: 1 is substituted with arginine or tyrosine.

2. The modified polypeptide according to claim 1 , wherein the modified polypeptide consists of an amino acid sequence selected from the group consisting of SEQ ID NOS: 21, 22, 23, 25, 26, 28, 29, 31, 32, 34 and 35.

3. A modified polypeptide having an isopropylmalate synthase activity, wherein arginine at position 558 from an N-terminus of a polypeptide consisting of the amino acid sequence of SEQ ID NO: 1 is substituted with histidine, alanine, or glutamine, and glycine at position 561 from an N-terminus of a polypeptide consisting of the amino acid sequence of SEQ ID NO: 1 is substituted with aspartic acid, arginine, or tyrosine.

4. The modified polypeptide according to claim 3 , wherein the modified polypeptide consists of an amino acid sequence selected from the group consisting of SEQ ID NOS: 27, 30, and 33.

5. A polynucleotide encoding the modified polypeptide of claim 1 .

6. The polynucleotide according to claim 5 , wherein the polynucleotide consists of a nucleotide sequence selected from the group consisting of SEQ ID NOS: 36, 37, 38, 40, 41, 43, 44, 46, 47, 49 and 50.

7. A polynucleotide encoding the modified polypeptide of claim 2 .

8. A polynucleotide encoding the modified polypeptide of claim 3 .

9. The polynucleotide according to claim 8 , wherein the polynucleotide consists of a nucleotide sequence selected from the group consisting of SEQ ID NOS: 42, 45, and 48.

10. A microorganism of the genus Corynebacterium producing L-leucine, which is transformed with a vector comprising a polynucleotide encoding a modified polypeptide having an isopropylmalate synthase activity, wherein arginine at position 558 from a N-terminus of the polypeptide consisting of the amino acid sequence of SEQ ID NO: 1 is substituted with an amino acid residue other than arginine; and/or glycine at position 561 from a N-terminus of the polypeptide consisting of the amino acid sequence of SEQ ID NO: 1 is substituted with an amino acid residue other than glycine.

11. A microorganism of the genus Corynebacterium producing L-leucine, comprising the modified polypeptide of claim 1 .

12. The microorganism according to claim 11 , wherein the microorganism of the genus Corynebacterium is Corynebacterium glutamicum.

13. A microorganism of the genus Corynebacterium producing L-leucine, comprising the modified polypeptide of claim 2 .

14. A microorganism of the genus Corynebacterium producing L-leucine, comprising the modified polypeptide of claim 3 .

15. A microorganism of the genus Corynebacterium producing L-leucine, comprising the modified polypeptide of claim 4 .

16. A method of producing L-leucine, comprising:

(a) culturing the microorganism of the genus Corynebacterium producing L-leucine according to claim 11 in a medium to produce L-leucine; and

(b) recovering L-leucine from the cultured microorganism or the cultured medium.

17. A method of producing L-leucine, comprising:

(a) culturing the microorganism of the genus Corynebacterium producing L-leucine according to claim 13 in a medium to produce L-leucine; and

(b) recovering L-leucine from the cultured microorganism or the cultured medium.

18. A method of producing L-leucine, comprising:

(a) culturing the microorganism of the genus Corynebacterium producing L-leucine according to claim 14 in a medium to produce L-leucine; and

(b) recovering L-leucine from the cultured microorganism or the cultured medium.

19. A method of producing L-leucine, comprising:

(a) culturing the microorganism of the genus Corynebacterium producing L-leucine according to claim 15 in a medium to produce L-leucine; and

(b) recovering L-leucine from the cultured microorganism or the cultured medium.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 25, 2019
From: LEE, JI HYE; SONG, BYEONG CHEOL; JEON, AE JI; KIM, JONG HYUN; KIM, HYE WON
To: CJ CHEILJEDANG CORPORATION
Reel/Frame 050486/0077 →
Priority Claims (1)
KR 10-2016-0181343 · Dec 28, 2016 · national
Continuity (1)
Related Publication 20200032305A1 · Jan 30, 2020